Items where Author is "Murnane, D."

Item Type No Grouping

Article

Characterization of latent heat-releasing phase change materials for dermal therapies. (2011) D.G. Wood, Marc Brown, S. A. Jones and D. Murnane picture_as_pdf

Formation and measurement of process induced disorder during the manufacture of inhalation medicines. (2011) P.G. Royall, B. Woodhead, S.J. Tang, G.P. Martin, B.M. Stockton and D. Murnane

Other

Particle aggregation of salmeterol xinafoate (SX) in HFA134a high pressure suspensions. (2006) D. Murnane, G.P. Martin and C. Marriott

Evidence for flocculation-controlled microcrystallisation of salmeterol xinafoate. (2006) D. Murnane, G.P. Martin, I. Haley and C. Marriott

Investigation of a reverse-phase high performance liquid chromatography (RP-HPLC) method for a weakly basic drug. (2005) D. Murnane, G. P. Martin and C. Marriott

Transiently supersaturated solutions from the dissolution of amorphous powders for topical drug delivery. (2010) I. A. Palmer, S. A. Jones, D. Murnane, M.J. Traynor, Gary Moss and Marc Brown

The effect of aerodynamic particle size and solid state disorder on salmeterol xinafoate deposition from pressurised metered dose and dry powder inhaler formulations. (2013) S. Jaffari, G. Sandhu, G. P. Martin, B. Forbes, E. Collins and D. Murnane

Assessment of a cyclone-type spacer device for use in dry powder inhalation. (2013) I. Parisini, S. J. Cheng, D. D. Symons, Marc Brown, A. Kostrzewski and D. Murnane